Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2003

Oct 30, 2003

34519_dirs_2003-10-30_b0b76619-140c-4b00-bc8e-17e5a0afe4ed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2003-10-28

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-10-28 Common Stock, par value $0.10 per share P 500 $2.97 Acquired 344560 Direct
2003-10-29 Common Stock, par value $0.10 per share P 100 $2.99 Acquired 344660 Direct
2003-10-30 Common Stock, par value $0.10 per share P 300 $3.11 Acquired 344960 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.